Investors

Some LPs have expressed scepticism around the return potential of LP-led secondaries, while interest in CVs is heating up.

Why emerging managers should buddy up with a weighty LP; the US regulator is wary of lengthy fund lives; why private credit's loss could be PE's gain.

An inside look at the $219bn pension’s buyout and growth performance, geographic and sector exposure and co-investment portfolio.

Institutional investors have justifiable concerns about how an influx of retail capital may impact the industry, writes Lori Hall-Kimm, senior managing director and global head of private equity at Healthcare of Ontario Pension Plan.

Private equity is expected to continue serving an important role in the overall portfolio of the pension, which is switching to a total portfolio approach in July.

How to supercharge UK private markets; why the 'T-word' isn't so outlandish for secondaries; the EU gets touchy around tech.

Members of the $219bn pension's investment advisory council weighed in on the relevance and sufficiency of performance benchmarks at a June meeting.

In today's edition, credit's redemption storm makes landfall in private equity; How secondaries is winning the talent war; LP demands are reshaping SPVs.

Florida SBA is considering a number of rebalancing initiatives, including LP-led secondaries activity, in order to reduce its venture capital exposure.

In today's edition, LPs are developing an aversion to mean reversion; Why 'dual use' and 'lethal' defence opportunities aren't mutually exclusive; What the SEC wants to know about your PE firm.